Literature DB >> 6944534

Naturally arising tumors of the inbred WAB/Not rat strain. II. Immunogenicity of transplanted tumors.

J G Middle, M J Embleton.   

Abstract

The immunogenicity of 28 transplanted naturally arising tumors of the inbred WAB/Not rat was investigated at early passages in strictly syngeneic, contemporary animals. Included were nephroblastomas, histologically benign and malignant mammary tumors, soft tissue and skin tumors, 1 lymphoid tumor, and 2 gastrointestinal lesions. In no case was evidence of immunogenicity observed when animals were treated with multiple grafts of irradiated (15,000 rad) tissue or by excision of a growing tumor. A few of these tumors were further investigated by other methods of immunization, including injection at various sites of irradiated cells followed by challenge at different sites and multiple injections of mitomycin C- or Formalin-treated cells. Again no evidence of immunogenicity was seen. Attempts to immunize with viable cells mixed with BCG or Corynebacterium parvum failed due to lack of tumor suppression by these agents. Limited concomitant immunity experiments yielded similarly negative results, except in one case of a fibrosarcoma for which a slight reduction in second tumor growth was observed when primary implants were very large. Some alterations in biologic properties during transplant passage and the incidence of postexcision recurrence and metastatic spread of some of the tumors are described.

Entities:  

Mesh:

Year:  1981        PMID: 6944534

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Clinical trials of immunotherapy.

Authors:  H Hewitt
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-08

Review 2.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Natural cytotoxicity in lymphatic metastasis. I. In vitro studies using the rat tumor BSp73 and its variants.

Authors:  S Matzku; H P Oberneder; R Keller; M Zöller
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 4.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 5.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

6.  Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts.

Authors:  P Siesjö; E Visse; M Lindvall; L Salford; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

7.  Therapeutic anti-tumor vaccines: from tumor inhibition to enhancement.

Authors:  Paula Chiarella; Verónica Reffo; Juan Bruzzo; Oscar D Bustuoabad; Raúl A Ruggiero
Journal:  Clin Med Oncol       Date:  2008-04-29

8.  Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.

Authors:  P L Ward; H Koeppen; T Hurteau; H Schreiber
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

9.  "Concomitant immunity" in murine tumours of non-detectable immunogenicity.

Authors:  R A Ruggiero; O D Bustuoabad; R D Bonfil; R P Meiss; C D Pasqualini
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

10.  Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.

Authors:  A Van Pel; F Vessière; T Boon
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.